Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-1.29
↑ 74% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-4.91
Historical baseline
PeriodValueYoY Change
2024-1.29+22.9%
2023-1.67+28.4%
2022-2.33+39.9%
2021-3.88+54.8%
2020-8.58+26.9%
2019-11.73-